Belite Bio annual operating expenses
2020
2021
2022
2023
2024
2025
Belite Bio Operating Expenses Growth & History (BLTE)
Belite Bio's operating expenses was $84.2M for fiscal 2025.
View full Belite Bio company overviewBelite Bio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $84.2M | $44.2M | +110.54% |
| 2024 | 2024-12-31 | $40.0M | $8.3M | +26.30% |
| 2023 | 2023-12-31 | $31.7M | $18.8M | +147.00% |
| 2022 | 2022-12-31 | $12.8M | $3.0M | +30.87% |
| 2021 | 2021-12-31 | $9.8M | $4.1M | +70.59% |
| 2020 | 2020-12-31 | $5.7M | — | — |
Belite Bio quarterly operating expenses
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $34.9M | $17.3M | +98.38% |
| Q1 2026 | 2026-03-31 | $32.7M | $17.2M | +110.63% |
| Q4 2025 | 2025-12-31 | $28.1M | — | — |
| Q3 2025 | 2025-09-30 | $23.0M | — | — |
| Q2 2025 | 2025-06-30 | $17.6M | — | — |
| Q1 2025 | 2025-03-31 | $15.5M | — | — |
Belite Bio operating expenses trends
Over the last five fiscal years, Belite Bio's operating expenses increased from $5.7M to $84.2M, a change of $78.5M. The latest reported quarter, Q2 2026, shows $34.9M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Belite Bio source filings ↗